Novartis-has-announced-the-results-of-phase-4-INSTEAD-study
Novartis has announced the results of phase 4 INSTEAD study
Novartis has announced the result of a Phase 4 INSTEAD research made to imporve its new COPD drug. Once-daily indacaterol has shown very promising data....
Tags: durg development, INSTEAD Swift study, GSK, Novartis, pharmaceutical news, pharmaceutical companies...
April 29, 2014
Cytokinetics-failed-FDAs-approval
Cytokinetics failed FDA's approval
Cytokinetics' new ASÉ drug has failed clinical trials and was not approved by FDA. The drug has not reached the efficiency endpoint, therefore further research is going to be needed....
Tags: drug, drug discovery, ASL drug, Cytokinetics asl drug, FDA approval, FDA approval of asl drugs....
April 29, 2014
Ebola-a-survivors-diary
Ebola: a survivors diary
From 208 patients of Ebola in Guinea 136 has already died. There is still no cure for this disease, however, treatments can help patients' bodies in order to develop antibodies. A survivor tells his story. ...
Tags: ebola, survivor, survivin ebloa, ebola guinea, ebola cure, antibody...
April 29, 2014
AstraZeneca-suffers-17-fall-but-still-stands
AstraZeneca suffers 17% fall, but still stands
Astra zeneca suffered 17% loss on stock exchange due to patent loosings of veteran drugs. However, the company is still positive about its future and hopes to regain what it has lost....
Tags: pharma, pharmaceutical companies, pharma loss, Astra Zeneca, veteran drugs...
April 29, 2014
Nast-bathrooms-on-Suns-plant
Nastí bathrooms on Sun's plant
Sun Pharmaceutical's $3.2 billion buyout offer for Ranbaxy Laboratories also came with a pledge to clean up the act of India's largest generic drugmaker, which has had four plants banned by the FDA. But Sun also recently had a plant nixed by the FDA, and Bloomberg learn...
Tags: india, pharma, indian pharma, FDA, FDA ban, sun ban, ...
April 29, 2014
Patient-participation-can-increase-the-efficiency-of-pain-treatment
Patient participation can increase the efficiency of pain treatment
According to the freshest data, those patients who are involved in the process of their operation, medication or pain treatment are usually more satisfied by the results. ...
Tags: pain, pain management, pain treatment, paint medication, painkiller, operation, patients participation, patient involved...
April 29, 2014
Provair-has-introduced-better-well-storages
Provair has introduced better well-storages
Provair is starting to spread its new silicone storage system. The 2 ml well storages are suitable for mechanical sample preparation too. O-ring cups are available in round and edgy shapes as well....
Tags: provair, well-storages, sample preaparation, pharmaceutical products, technical support....
April 29, 2014
How-come-snails-to-medical-research
How come snails to medical research?
Scientists have found T-type channels in a certain type of snail. These channes can accquire different ions and produce electric signals. These might be the peacemakers in our brains and hearts too....
Tags: snail, snail research, T-type channels, peacemaker...
April 29, 2014
There-is-a-smarter-form-of-you-right-in-your-head
There is a smarter form of you right in your head
Certain apps can help us to discover the smarter ourselves according to studies. New ways of biomechanical and neurotical research....
Tags: neurotical research, biomechanical researxh, clever, smarter, brain...
April 29, 2014
Novartis-experiences-a-solid-growth
Novartis experiences a solid growth
Perhaps as the result of definitive agreements with GSK and Eli Lilly, Novartis announced that it has produced a solid growth in the subsequent quarter's end. ...
Tags: Novartis, sotck growth, pharmaceutical growth, novartis stocks...
April 29, 2014
The-freshest-news-about-Hepatitis-C-cure-news
The freshest news about Hepatitis-C cure news
Experts predict that we are going to hear several news about new invetions in the field of hepatitis C research. The most popular seems to be Sovaldi, but several others are planned too....
Tags: Sovaldi, hepatitis C, hepatitis c research, hepatitis C medicine...
April 29, 2014
The-price-of-AstraZeneca-s-stock-increased-after-Pfizers-offer
The price of AstraZeneca 's stock increased after Pfizer's offer
The price of AstraZeneca stocks runned up after Pfizer announced that it is willing to buy o buy the company for around $100 billion. Lately, AstraZeneca turned down another similar offer. ...
Tags: Stock, pharmaceutival business, pharmaceutical companies, AstraZeneca, Pfizer, pharmaceutical stock exchange, pharma stocks, astrazeneca sold...
April 29, 2014
MOST VIEWED

HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013